The locus coeruleus contributes to the anorectic, nausea, and autonomic physiological effects of glucagon-like peptide-1
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Increasing the therapeutic potential and reducing the side effects of U.S. Food and Drug Administration-approved glucagon-like peptide-1 receptor (GLP-1R) agonists used to treat obesity require complete characterization of the central mechanisms that mediate both the food intake-suppressive and illness-like effects of GLP-1R signaling. Our studies, in the rat, demonstrate that GLP-1Rs in the locus coeruleus (LC) are pharmacologically and physiologically relevant for food intake control. Furthermore, agonism of LC GLP-1Rs induces illness-like behaviors, and antagonism of LC GLP-1Rs can attenuate GLP-1R-mediated nausea. Electrophysiological and behavioral pharmacology data support a role for LC GLP-1Rs expressed on presynaptic glutamatergic terminals in the control of feeding and malaise. Collectively, our work establishes the LC as a site of action for GLP-1 signaling and extends our understanding of the GLP-1 signaling mechanism necessary for the development of improved obesity pharmacotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4. LC GLP-1R activation increases glutamate signaling onto LC NE neurons. (A) Voltage-clamp electrophysiology recordings of TH+ enhanced green fluorescent protein–labeled LC NE neurons. (B) Representative traces showing bath applied Ex-4 (1 μM) increased the frequency of spontaneous excitatory postsynaptic currents (EPSCs). Bath application of the AMPA-type glutamate receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]quinoxaline (NBQX) eliminated the phasic waveforms. (C) The majority of recorded neurons (n = 8 of 10, 80%) responded to bath applied Ex-4. (D) Ex-4 significantly increased the frequency of spontaneous EPSCs. (E) Ex-4 also increased the amplitude of EPSCs in responsive neurons (n = 8). (F) The decay kinetics (tau) were not affected by Ex-4 application relative to control (n = 8). All data were expressed as means (D and F) or median (E) ± SEM. All data were analyzed with paired Student’s t tests (D and F) or Wilcoxon signed-rank test (E). Means with different letters are significantly different from each other (P < 0.05).](https://figures.cochat.ai/paper-figures/825def3c8e204feaa3b0f7bfa306bd6a/the-locus-coeruleus-contributes-to-the-anorectic-nausea-and-autonomic-figure-4.jpg)
![Fig. 5. LC GLP-1R activation contributes to food intake control via enhanced glutamate signaling. (A) RNAscope analysis did not reveal Glp1r mRNA expression in LC NE neuron (DBH) soma. (B) LC NE neurons express N-methyl-d-aspartate (NMDA) receptors (Grin1A). (C) LC NE neurons express AMPA receptors (GluA1). (D) Pretreatment with an NMDA/AMPA antagonist cocktail [GluR antag; MK-801, 0.05 μg/CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), 0.3 μg] attenuated the food intake-suppressive effects of LC Ex-4 (0.05 μg) at 3 and 6 hours after administration (n = 20). (E) MK-801/CNQX attenuated the food intake suppressive effects of LC Ex-4 at 24 hours (n = 20). (F) Twenty-four-hour body weight reduction by LC Ex-4 was not significantly affected by MK-801/CNQX pretreatment (n = 20). (G) Proposed mechanism by which LC GLP-1R activation increases LC NE activity, suppresses food intake, and causes illness-like and autonomic effects. All data were expressed as means ± SEM. Data in (D) to (F) were analyzed with a repeated-measures two-way ANOVA at each time point followed by Newman-Keuls post hoc tests. Means with different letters are significantly different from each other (P < 0.05). DAPI, 4′,6-diamidino-2-phenylindole.](https://figures.cochat.ai/paper-figures/d8990f912a894de7800b49eacc5f38c1/the-locus-coeruleus-contributes-to-the-anorectic-nausea-and-autonomic-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The individual necessity of distinct GLP-1R neuron populations for the anorectic and weight loss effects of GLP-1RAs has now been claimed by multiple studies using various loss-of-function approaches in rodents (47, 50‐54, 69).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent mechanistic studies, primarily conducted in rodents, have identified a number of sites of direct action putatively mediating the effects of GLP-1-based AOMs on eating and body weight, including the area postrema and nucleus tractus solitarius (47‐49), locus coeruleus (50), hypothalamic arcuate (51, 52) and dorsomedial nuclei (53), and the lateral septal nucleus (54).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [50]
In the citing paper
“While the hypothalamic arcuate nucleus is the convergence region most investigated to date (20, 51, 52), several recent studies have provided evidence for roles in physiological and GLP-1RA AOM-mediated eating control for GLP-1R populations in the locus coeruleus (50), dorsomedial hypothalamus (53), and lateral septum (54) (Fig. 1B).”
From GLP-1 and the Neurobiology of Eating Control: Recent Advances (2025) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
The economic burden of obesity worldwide: a systematic review of the direct costs of obesity
Withrow, D., & Alter, D. A. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00712.x · Cited by 1,083 · cited 1×
“INTRODUCTION Obesity currently affects 42% of adults and 19% of children in the United States (1), creating an enormous health and economic burden (2, 3).”
BackgroundOrienting and reorienting: the locus coeruleus mediates cognition through arousal
Sara, S. J., & Bouret, S. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.011 · Cited by 1,056 · cited 1×
“Future work will examine the contribution of LC GLP-1Rs to LC NE signaling–induced changes in stress, anxiety, and aversion (71–73) in addition to arousal (74), foraging behavior (75), and sensory encoding that includes taste perception (76, 77); all of which may contribute to the observed food intake reduction follow…”
BackgroundParaventricular Nucleus:A Site for the Integration of Neuroendocrine and Autonomic Mechanisms
Swanson, L. W., & Sawchenko, P. E. (1980) · Neuroendocrinology · doi:10.1159/000123111 · Cited by 997
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961
Jones, B. E., & Yang, T. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902420105 · Cited by 896
Dombrowski, S. U., Knittle, K., Avenell, A., Araujo-Soares, V., & Sniehotta, F. F. (2014) · BMJ · doi:10.1136/bmj.g2646 · Cited by 816
Cited by
GLP-1 and Its Analogs: Does Sex Matter?
Börchers, S., & Skibicka, K. P. (2025) · Endocrinology · doi:10.1210/endocr/bqae165 · Cited by 77
Merkel, R., Hernandez, N. S., Weir, V. R., Zhang, Y., Caffrey, A., Rich, M. T., Crist, R. C., Reiner, B. C., & Schmidt, H. D. (2025) · Science Advances · doi:10.1126/sciadv.adr5051 · Cited by 79
Chen, Z., Deng, X., Shi, C., Jing, H., Tian, Y., Zhong, J., Chen, G., Xu, Y., Luo, Y., & Zhu, Y. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178239 · Cited by 48
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Jones, L. A., & Brierley, D. I. (2025) · Endocrinology · doi:10.1210/endocr/bqae167 · Cited by 43
GDF15 links adipose tissue lipolysis with anxiety
Townsend, L. K., Wang, D., Knuth, C. M., Fayyazi, R., Mohammad, A., Becker, L. J., Tsakiridis, E. E., Desjardins, E. M., Patel, Z., Valvano, C. M., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01264-3 · Cited by 50
Metadata
- Authors
- Fortin, S. M., Chen, J. C., Petticord, M. C., Ragozzino, F. J., Peters, J. H., & Hayes, M. R.
- Affiliations
- University of Pennsylvania (US)
- Washington State University (US)
- Corresponding author
- Fortin, Samantha M.
- Hayes, Matthew R.
- ORCID
- Venue
- Science Advances
- Published
- 2023-09-22
- Volume
- 9
- Issue
- 38
- Pages
- eadh0980-eadh0980
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC10511187
- OpenAlex
- W4386905965
- Cited by
- 32
- References
- 123
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 8 · 2023: 1
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Science Advances (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK115762, R01DK021397, R56DK115762, R56DK021397, K01DK133627)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- locus coeruleus, glucagon-like peptide-1, GLP-1 receptor agonists, food intake regulation, nausea, anorectic effect, autonomic nervous system, malaise, obesity pharmacotherapy
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Appetite Depressants, Locus Coeruleus, Nausea, Obesity, United States, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.